CanSino Biologics Inc. (6185) Announces Plan to Use Reserves to Offset Accumulated Losses

Bulletin Express

Nov 07

CanSino Biologics Inc. (6185) announced a proposal to use reserves to cover its parent company’s accumulated losses as of December 31, 2024. According to the 2024 annual financial statements, the parent company had losses totaling RMB1,450,342,128.90, a surplus reserve of RMB118,388,703.29, and a capital reserve of RMB6,576,729,725.03.

The plan involves using RMB118,388,703.29 from the surplus reserve and RMB1,331,953,425.61 from the capital reserve to fully offset the RMB1,450,342,128.90 in accumulated losses. Upon completion, the surplus reserve will be reduced to zero, and the capital reserve will stand at RMB5,244,776,299.42.

This proposal was approved at the third extraordinary meeting of the third session of the Board of Directors on November 7, 2025, and will be submitted for shareholder approval at the 2025 second extraordinary general meeting. The company indicates that this move aims to support high-quality development and enhance its capacity to deliver investor returns.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1133486251"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133486251\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133486251?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133486251","market":"hk","top_or_hot":-1,"title":"CanSino Biologics Inc. (6185) Announces Plan to Use Reserves to Offset Accumulated Losses","media":"Bulletin Express","content":"<p>CanSino Biologics Inc. (6185) announced a proposal to use reserves to cover its parent company’s accumulated losses as of December 31, 2024. According to the 2024 annual financial statements, the parent company had losses totaling RMB1,450,342,128.90, a surplus reserve of RMB118,388,703.29, and a capital reserve of RMB6,576,729,725.03.</p>\n<p>The plan involves using RMB118,388,703.29 from the surplus reserve and RMB1,331,953,425.61 from the capital reserve to fully offset the RMB1,450,342,128.90 in accumulated losses. Upon completion, the surplus reserve will be reduced to zero, and the capital reserve will stand at RMB5,244,776,299.42.</p>\n<p>This proposal was approved at the third extraordinary meeting of the third session of the Board of Directors on November 7, 2025, and will be submitted for shareholder approval at the 2025 second extraordinary general meeting. The company indicates that this move aims to support high-quality development and enhance its capacity to deliver investor returns.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CanSino Biologics Inc. (6185) Announces Plan to Use Reserves to Offset Accumulated Losses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanSino Biologics Inc. (6185) Announces Plan to Use Reserves to Offset Accumulated Losses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-07 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CanSino Biologics Inc. (6185) announced a proposal to use reserves to cover its parent company’s accumulated losses as of December 31, 2024. According to the 2024 annual financial statements, the parent company had losses totaling RMB1,450,342,128.90, a surplus reserve of RMB118,388,703.29, and a capital reserve of RMB6,576,729,725.03.</p>\n<p>The plan involves using RMB118,388,703.29 from the surplus reserve and RMB1,331,953,425.61 from the capital reserve to fully offset the RMB1,450,342,128.90 in accumulated losses. Upon completion, the surplus reserve will be reduced to zero, and the capital reserve will stand at RMB5,244,776,299.42.</p>\n<p>This proposal was approved at the third extraordinary meeting of the third session of the Board of Directors on November 7, 2025, and will be submitted for shareholder approval at the 2025 second extraordinary general meeting. The company indicates that this move aims to support high-quality development and enhance its capacity to deliver investor returns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1133486251","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133486251","pubTimestamp":1762504913,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CanSino Biologics Inc. (6185) announced a proposal to use reserves to cover its parent company’s accumulated losses as of December 31, 2024. According to the 2024 annual financial statements, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"康希诺生物股份公司(6185)公布拟动用储备抵销累计亏损","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"CanSino Biologics Inc. (6185) announced a proposal to use reserves to cover its parent company’s accumulated losses as of December 31, 2024. According to the 2024 annual financial statements, the parent company had losses totaling RMB1,450,342,128.90, a surplus reserve of RMB118,388,703.29, and a capital reserve of RMB6,576,729,725.03.\nThe plan involves using RMB118,388,703.29 from the surplus reserve and RMB1,331,953,425.61 from the capital reserve to fully offset the RMB1,450,342,128.90 in accumulated losses. Upon completion, the surplus reserve will be reduced to zero, and the capital reserve will stand at RMB5,244,776,299.42.\nThis proposal was approved at the third extraordinary meeting of the third session of the Board of Directors on November 7, 2025, and will be submitted for shareholder approval at the 2025 second extraordinary general meeting. The company indicates that this move aims to support high-quality development and enhance its capacity to deliver investor returns.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}